Clinical trial
Evaluation of the Efficacy and Safety of Levocetirizine During 8 Weeks Preceding and Following the Anticipated Onset of the Grass Pollen Season in Subjects Suffering From Seasonal Allergic Rhinitis Associated With Pollen-induced Asthma
NCT00521040 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy and Safety of Levocetirizine During 8 Weeks Preceding and Following the Anticipated Onset of the Grass Pollen Season in Subjects Suffering From Seasonal Allergic Rhinitis Associated With Pollen-induced Asthma
- Lead sponsor
- UCB Pharma
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 29, 2004
- Completion date
- July 31, 2004
- Enrollment
- 459 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.